The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
Open accessAbstract
The emergence of influenza A viruses which had acquired resistance to rimantadine during a clinical trial (C. B. Hall, R. Dolin, C. L. Gala, D. M. Markovitz, Y. Q. Zhang, P. H. Madore, F. A. Disney, W. B. Talpey, J. L. Green, A. B. Francis, and M. E. Pichichero, Pediatrics 80:275-282, 1987) provided the opportunity to determine the genetic basis of this phenomenon. Analysis of reassortant viruses generated with a resistant clinical isolate (H3N2) and the susceptible influenza A/Singapore/57 (H2N2) virus indicated that RNA segment 7 coding for matrix and M2 proteins conferred the resistant phenotype. Resistant viruses isolated from seven patients each contained a single change in the nucleotide sequence coding for the M2 protein which resulted in substitutions in amino acid 30 (two viruses) or 31 (five viruses) in the transmembrane domain of the molecule. These changes occurred in locations identified in influenza viruses selected for resistance to amantadine in tissue culture and indicate a common mechanism of action of the two compounds in cell culture and during chemotherapeutic use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The molecular basis of the specific anti-influenza action of amantadine.
Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 847
Self-citationAntiviral Activity of 1-Adamantanamine (Amantadine)
Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C., & Hoffmann, C. E. (1964) · Science · doi:10.1126/science.144.3620.862 · Cited by 838
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface
Lamb, R. A., Zebedee, S. L., & Richardson, C. D. (1985) · Cell · doi:10.1016/0092-8674(85)90211-9 · Cited by 576
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
Dolin, R., Reichman, R. C., Madore, H. P., Maynard, R., Linton, P. N., & Webber-Jones, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209023071002 · Cited by 501
Lamb, R. A., Lai, C. J., & Choppin, P. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4170 · Cited by 325
Plaque inhibition assay for drug susceptibility testing of influenza viruses
Hayden, F. G., Cote, K. M., & Douglas, R. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.5.865 · Cited by 278
Wingfield, W. L., Pollack, D., & Grunert, R. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909112811102 · Cited by 234
Successful Treatment of Naturally Occurring Influenza A/USSR/77 H1N1
Van Voris, L. P. (1981) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1981.03310360020016 · Cited by 212
Children With Influenza A Infection: Treatment With Rimantadine
Hall, C. B., Dolin, R., Gala, C. L., Markovitz, D. M., Zhang, Y. Q., Madore, P. H., Disney, F. A., Talpey, W. B., Green, J. L., Francis, A. B., et al. (1987) · Pediatrics · doi:10.1542/peds.80.2.275 · Cited by 196
Self-citation
Cited by
A universal influenza A vaccine based on the extracellular domain of the M2 protein
Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., & Fiers, W. (1999) · Nature Medicine · doi:10.1038/13484 · Cited by 752
Bright, R. A., Medina, M.-J., Xu, X., Perez-Oronoz, G., Wallis, T. R., Davis, X. M., Povinelli, L., Cox, N. J., & Klimov, A. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67338-2 · Cited by 725
Bright, R. A. (2006) · JAMA · doi:10.1001/jama.295.8.joc60020 · Cited by 671
Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., Krauss, S., Shortridge, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160270697 · Cited by 626
Self-citationDeyde, V. M., Xu, X., Bright, R. A., Shaw, M., Smith, C. B., Zhang, Y., Shu, Y., Gubareva, L. V., Cox, N. J., & Klimov, A. I. (2007) · The Journal of Infectious Diseases · doi:10.1086/518936 · Cited by 543
Metadata
- Authors
- Belshe, R. B., Smith, M. H., Hall, C. B., Betts, R., & Hay, A. J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1988-05
- Volume
- 62
- Issue
- 5
- Pages
- 1508-1512
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1766393696
- Cited by
- 287
- References
- 16
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. https://app.cochat.ai/papers/10.1128/jvi.62.5.1508-1512.1988
- The paper
- Belshe, R. B., Smith, M. H., Hall, C. B., Betts, R., & Hay, A. J. (1988). Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. Journal of Virology. https://doi.org/10.1128/jvi.62.5.1508-1512.1988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.